Patients with hormone-sensitive cancers may lower their risk of breast cancer recurrence by increasing their soy intake, according to a study published in the Canadian Medical Association Journal (2010 Oct 18. [Epub ahead of print]).
Zoledronic acid is more effect than clodronate at treating patients with newly diagnosed multiple myeloma and improves survival.
Chemoradiotherapy improves survival in patients with locally advanced cervical cancer compared to treatment with radiotherapy alone.
Researchers have conducted an analysis that will help them understand survival 5 years after the diagnosis of malignant tumors in Spain, according to an investigation published in the journal Annals of Oncology (2010 May;21 Suppl 3:iii90-96).
Survival and response to treatment in advanced prostate cancer can be predicted by the number of circulating tumour cells (CTCs), a study has shown
Long-term survival in prostate cancer patients can be predicted by prostate-specific antigen (PSA) values at 2 years posttreatment, say researchers from Memorial Sloan-Kettering Cancer Center.
Women with early-stage HER2-positve breast cancer are at significant risk of recurrence, according to a study published in the Journal of Clinical Oncology (2009 Nov 2 [Epub ahead of print].
Survival rates increase for patients who are treated with Gamma Knife radiosurgery, according to results of a study presented at the American Society for Radiation Oncology (ASTRO) meeting in Chicago.
